CASI Pharmaceuticals Inc
Biotechnology
Healthcare
CASI
15.00 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
1.93
52 week high
7.55
high
2.37
52 week low
2.01
previous Close
2.04
P/E ratio
market cap
86.58 M
div yield
0
net incoming
-8.40 M
-20.53 %
net profit margin
-107.72 %
67.00 %
operating incoming
-8.46 M
3.70 %
net change in cash
0.00 %
cash on hand
16.54 M
73.47 %
cost of revenue
3.75 M
96.03 %
top